Consolidated figures · ₹ crore
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 194 | 239 | 278 | |
| COGS | 49 | 57 | 82 |
| Gross profit | 145 | 182 | 196 |
| 121 | 133 | 150 | |
| 24 | 49 | 46 | |
| OPM % | 12.3% | 20.5% | 16.5% |
| Depreciation | 12 | 15 | 16 |
| Interest | 5 | 5 | 1 |
| 2 | 10 | 3 | |
| Profit before tax | 16 | 38 | 31 |
| Tax | -9 | 6 | 3 |
| Tax % | -59.6% | 16.9% | 8% |
| 25 | 32 | 29 | |
| PAT margin % | 13% | 13.3% | 10.4% |
| EPS (₹) | — | 6.1 | 5.5 |
| EPS adjusted (₹) | 162.8 | 5.8 | 5.3 |
| Annual report | — | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 0 | 0 | 11 | 11 |
| Reserves | — | 42 | 198 | 232 |
| Minority interest | — | 2 | 0 | 1 |
| — | 42 | 11 | 0 | |
| — | 48 | 65 | 50 | |
| Total equity & liabilities | — | 135 | 285 | 294 |
| 39 | 45 | 51 | 63 | |
| CWIP | — | — | — | 0 |
| Investments | — | 6 | 10 | 27 |
| — | 83 | 224 | 204 | |
| Total assets | — | 135 | 285 | 294 |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 8 | 44 | -5 | |
| -11 | -29 | -80 | |
| -3 | 111 | -18 | |
| Net cash flow | -5 | 125 | -102 |
| Free cash flow | -6 | 29 | -21 |
| CFO / Operating profit % | 34.3% | 104.7% | -11.5% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Laboratory Business | 196.87 | 30.19 | 0 | 0 |
| Aligners Business | 76.65 | 14.44 | 0 | 0 |
| Other business | 8.64 | -1.23 |
| 0 |
| 0 |
₹ crore by fiscal year